Instrucciones de búsqueda:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Navegar por los elementos (133 total)
-
Autor: FDA
Tema: Treatment & Care
Tipo de elemento: Guía
Fecha de actualización: 2022-04
Descripción: JYNNEOS is a vaccine indicated for prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection.Includes: indications and usage, dosage and administration, dosage… -
Autor: CDC
Tema: Treatment & Care
Tipo de elemento: Guía
Fecha de actualización: 2022-08-23
Descripción: VACCINE INFORMATION STATEMENT -
Autor: NETEC
Tema: Treatment & Care
Tipo de elemento: Video
Fecha de actualización: 2022-09-09
Descripción: In this video, we demonstrate the technique of intradermal medication administration. In the 2022 monkeypox outbreak, this technique is being used to administer the Jynneos smallpox and monkeypox vaccine in order to increase the number of available… -
Autor: WHO
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2022-08-19
Descripción: The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. -
Autor: NETEC
Tema: Treatment & Care
Tipo de elemento: Guía
Fecha de actualización: 2022-08-23
Descripción: As the 2022 global mpox outbreak continues to spread in the U.S. and abroad, pediatricians should consider how mpox may affect their patients. This blog post provides information related to mpox and pediatrics. -
Autor: Herminia Machry, Zorana Matić, Yeinn Oh, Jennifer R DuBose, Jill S Morgan, Kari L Love, Jesse T Jacob, Craig M Zimring
Tema: Infection Control
Tipo de elemento: Publicación
Fecha de actualización: 2022-02-14
Descripción: Understand how the built environment can affect safety and efficiency outcomes during doffing of personal protective equipment (PPE) in the context of coronavirus disease 2019 (COVID-19) patient care.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Autor: Jocelyn J Herstein, Paul D Biddinger, Shawn G Gibbs, Angela L Hewlett, Aurora B Le, Michelle M Schwedhelm, John J Lowe
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2022-02-22
Descripción: In response to the 2014-2016 West Africa Ebola virus disease (EVD) epidemic, the Centers for Disease Control and Prevention (CDC) designated 56 US hospitals as Ebola treatment centers (ETCs) with high-level isolation capabilities. We aimed to… -
Autor: ACTT- Study Group
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2022-05-23
Descripción: Baricitinib and dexamethasone have randomised trials supporting their use for the treatment of patients with COVID-19. We assessed the combination of baricitinib plus remdesivir versus dexamethasone plus remdesivir in preventing progression to… -
Autor: NETEC
Tema: Treatment & Care
Tipo de elemento: Hipervínculo
Fecha de actualización: 2022-06-29
Descripción: On this episode of Transmission Interrupted, we welcome Dr. Jared Evans, Dr. Aneesh Mehta, and Dr. Vanessa Rabbe—members of NETEC’s Special Pathogen Research Network—to discuss their recent manuscript entitled, “Lassa Virus Infection: a Summary for… -
Autor: NETEC
Tema: Infection Control
Tipo de elemento: Hipervínculo
Fecha de actualización: 2022-06-13
Descripción: This blog post covers infection control, biocontainment, PPE, and related topics for Lassa Fever patients. Because of the high degree of mortality associated with infection, patients infected with or suspected to be infected with Lassa virus should…